DURHAM, NC, and LIEGE, BELGIUM - May 6, 2010, 8:00 CET - OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular diagnostics company in the field of cancer and pharmacogenomics, today issued its Q1 2010 business update, providing an overview of financial results and business highlights.
